The great deception: Tranexamic acid and extensive pulmonary emboli

17Citations
Citations of this article
32Readers
Mendeley users who have this article in their library.

Abstract

Pulmonary embolism (PE) is a common and life-threatening condition. The British Thoracic Society PE guidelines state that PE is reliably excluded in patients with low-intermediate clinical probability and a negative D-dimer. We are reporting the case of a 47-year-old lady, taking tranexamic acid for menorrhagia, who presented with shortness of breath and was diagnosed with extensive bilateral PE. She had a low clinical risk of PE as determined by her Wells score, and a subsequent negative D-dimer. This patient's D-dimer value of 15 ng/ml (HemosIL DD HS assay) was the lowest associated with any CT pulmonary angiogram (n=1645) recorded at our trust over a 2-year period. This lady was successfully treated with a heparin infusion and warfarin. No further thromboembolic events had occurred by 18-month follow-up. To our knowledge, this is the first case report to describe tranexamic acid causing an extremely low false-negative D-dimer masking PE. Copyright 2013 BMJ Publishing Group. All rights reserved.

Cite

CITATION STYLE

APA

Salam, A., King, C., Orhan, O., & Mak, V. (2013). The great deception: Tranexamic acid and extensive pulmonary emboli. BMJ Case Reports. https://doi.org/10.1136/bcr-2012-007808

Register to see more suggestions

Mendeley helps you to discover research relevant for your work.

Already have an account?

Save time finding and organizing research with Mendeley

Sign up for free